DLX-521

• Description:

  DLX-521 is an antibody that inhibits ALK. DLX-521 can be used in diagnosis and research for lung cancer[1].

• UNSPSC:

  12352203

• Target:

  Anaplastic lymphoma kinase (ALK)

• Related Pathways:

  Protein Tyrosine Kinase/RTK

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  Cancer

• References & Citations:

  [1]Santhoshi BANDLA, et al., Classification and Actionability Indices for Lung Cancer. US20160265065A1

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Inhibitory Antibodies

• Clinical Information:

  No Development Reported